Modular Medical Seeks Shareholder Approval for Reverse Stock Split and Substantial Increase in Authorized Shares Amidst Going Concern Warning

summarizeSummary

Modular Medical, Inc. is seeking shareholder approval for a reverse stock split to regain Nasdaq compliance and a significant increase in authorized common stock, signaling substantial future dilution and a critical need for capital to address its "going concern" status.

check_boxKey Events · Corporate Governance and Compliance · MODD

• Proposed Reverse Stock Split

  Shareholders will vote on a reverse stock split with a ratio between 1:5 and 1:40 to regain compliance with Nasdaq's $1.00 minimum bid price requirement, following a deficiency notice received on June 30, 2025.

• Substantial Increase in Authorized Shares

  The company is seeking to increase its authorized common stock from 100 million to 250 million shares, creating approximately 143 million unissued shares for future capital raises and corporate purposes. This represents a potential increase of over 180% relative to the 77.67 million shares currently outstanding.

• Equity Incentive Plan Expansion

  Shareholders will vote on adding 3 million shares to the 2017 Equity Incentive Plan, representing approximately 3.86% of current outstanding shares, aimed at attracting and retaining employees and directors.

• Going Concern Warning

  The filing reiterates a "substantial doubt" about the company's ability to continue as a going concern, highlighting the critical need for additional financing and the context for the proposed capital-raising measures.

auto_awesomeAnalysis · MODD · Industrial Applications And Services

Modular Medical, Inc.'s DEF 14A filing reveals a company in a precarious financial position, evidenced by its "going concern" disclosure and Nasdaq minimum bid price non-compliance. The proposed reverse stock split, with a wide ratio range, is a necessary step to maintain its Nasdaq listing, but such actions often precede further stock price weakness. More critically, the request to increase authorized shares by 150% (from 100 million to 250 million) indicates an urgent need for substantial future capital raises, which will result in significant dilution for existing shareholders. This, coupled with the proposed expansion of the equity incentive plan, underscores the company's struggle to fund operations and retain talent. Investors should be aware of the high likelihood of further dilution and the inherent risks associated with a company operating under a "going concern" warning.